Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (111 In)/Yttrium 90 (90 Y) Ibritumomab Tiuxetan (Zevalin ®) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels.

Autor: Wahl, Richard L.1,2,3 (AUTHOR) efrey@jhmi.edu, Frey, Eric C.1,2,4 (AUTHOR) jbianco@uwisc.edu, Jacene, Heather A.2,5 (AUTHOR) wkaseca@comcast.net, Kahl, Brad S.6,7 (AUTHOR) bkahl@wustl.edu, Piantadosi, Steven1,8 (AUTHOR) miah.jung@fda.hhs.gov, Bianco, Jesus A.2,6 (AUTHOR) gsgouros@jhmi.edu, Hammes, Richard J.6 (AUTHOR), Jung, Miah1 (AUTHOR) bhe@jhmi.edu, Kasecamp, Wayne2 (AUTHOR), He, Bin1,4 (AUTHOR) iflinn@tnonc.com, Sgouros, George2 (AUTHOR), Flinn, Ian W.1,9 (AUTHOR) lswinne1@jhmi.edu, Swinnen, Lode J.1 (AUTHOR)
Zdroj: Cancers. Jun2021, Vol. 13 Issue 11, p2828. 1p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje